Skip to content
Home/Companies/Biotech/Univercells
UN

Univercells

Biotech·Belgium·Exited 2023

Univercells is a biotech company, headquartered in Belgium.

Entry
–
Hold
–
Exit
2023
Est. EV
–

Who owns Univercells?

Univercells was owned by AdBio Partners through AFB Fund I (2021 vintage), exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-07

AdBio Partners
Investor
AdBio Partners
AFB Fund I · 2021 · VC

Key facts

HQBelgium
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from AFB Fund I

Other portfolio companies in the same fund.

Orikine Bio
Active
HealthcareSpain· 2026
AndzonBio2
Active
HealthcareFrance· 2025
Cephagenix
Active
HealthcareDenmark· 2025
EvlaBio
Active
HealthcareGermany· 2025
AndzonBio1
Active
HealthcareFrance· 2024
Anoat Therapeutics
Active
HealthcareFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings